¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Infections specific to the perinatal period, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® specific gravity ÇÑ±Û ºñÁß
¼³¸í   
  ´ÜÀ§ ºÎÇÇ´ç Áú·®. ¼Òº¯ÀÇ ºñÁßÀº ¼Òº¯ÀÇ ³óµµ¸¦ ¹Ý¿µÇÑ´Ù. ¿¹¸¦ µé¾î ¼Òº¯ÀÇ ºñÁßÀÌ Å©¸é, ÄáÆÏÀÇ ¹°Èí¼ö°¡ ¿øÈ°È÷ ÀÌ·ç¾îÁö°í ÀÖÀ½À» ³ªÅ¸³½´Ù.
  
  
¿µ¹® incubation period, latent stage ÇÑ±Û Àẹ±â, ¹è¾ç±â°£
¼³¸í   
  1. º´¿øÃ¼°¡ Ã¼³»¿¡ Ä§ÀÔ(°¨¿°)ÇÑ ÈÄ ±×·Î ÀÎÇÑ °¨¿°ÁõÀÌ ¹ßº´ÇÒ ¶§±îÁöÀÇ ±â°£. º´¿øÃ¼ÀÇ Á¾·ù¿¡ µû¶ó ±× ³»¿ëÀÌ ´Ù¸£´Ù. ¿¹ÄÁ´ë ¸»¶ó¸®¾Æ´Â Ä§ÀÔÇÑ º´¿øÃ¼°¡ ÀÎü ³»¿¡¼­ ÀÏÁ¤ÇÑ ´Ü°è±îÁö ¹ßÀ°ÇÑ ÈÄ ¹ßº´Çϰí, ÀåÆ¼Çª½º´Â Ä§ÀÔÇÑ º´¿ø±ÕÀÌ ÀÏÁ¤ÇÑ ¼ö±îÁö ¹ø½ÄÀ» Çؾߠ¹ßº´Çϸç, ÆÄ»ódzÀº Ä§ÀÔÇÑ º´¿ø±ÕÀÌ »ý¼ºÇÑ µ¶¼Ò°¡ ³ú½Å°æ¿¡ ´ÞÇÑ ÈÄ¿¡ ¹ßº´ÇÑ´Ù. °°Àº º´À̶󵵠ħÀÔÇÑ º´¿øÃ¼ÀÇ ¾çÀ̳ª µ¶·Â, °¨¿°µÈ »ç¶÷ÀÇ °¨¼ö¼º µî¿¡ µû¶ó¼­µµ ´Þ¶óÁø´Ù. º¸Åë Àẹ±â¿¡´Â º´Àû Â¡Èİ¡ ³ªÅ¸³ªÁö ¾ÊÁö¸¸ ¹Î°¨ÇÑ »ç¶÷ÀÇ °æ¿ì´Â µÎÅë-½Ä¿åºÎÁø-Çö±âÁõ-ºÒÄè°¨°ú °°Àº Àü±¸Áõ»óÀ» ³ªÅ¸³»´Â ¼öµµ ÀÖ´Ù. 2. º¸¿Â±â°£, ¹è¾ç±â°£, ¹ßÀ°¿¡ ÇÊ¿äÇÑ ±â°£. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • perinatal period
    Ãâ»ýÀüÈıâ
  • perinatal
    Ãâ»ýÀüÈıâ-, ÁÖ»ê±â-
  • perinatal mortality
    Ãâ»ýÀüÈıâ»ç¸Á·ü, ÁÖ»ê±â»ç¸Á·ü
  • perinatal mortality rate
    Ãâ»ýÀüÈıâ»ç¸Á·ü, ÁÖ»ê±â»ç¸Á·ü
  • age-period cohort analysis
    ¿¬·É±â°£ÄÚȣƮºÐ¼®
  • absolute refractory period
    Àý´ëºÒÀÀ±â
  • communicable period
    Àü¿°±â
  • childbearing period
    ÀӽŰ¡´É±â°£
  • definitive fetal period
    žƿϼº±â
  • extrinsic incubation period
    ¹Ù±ùÀẹ±â, ¿ÜÀẹ±â
  • ejection period
    ¹ÚÃâ±â
  • embryonic period
    ¹è¾Æ±â
  • fetal period
    žƱâ
  • functional refractory period
    ±â´ÉÀûºÒÀÀ±â
  • gestational period
    ÀӽűⰣ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • platelet-specific antigen
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
  • specific activity
    ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
  • specific gravity
    ºñÁß
  • specific phobia
    ƯÁ¤°øÆ÷(Áõ)
  • specific
    ƯÀÌ-, ƯÁ¤-
  • period
    ÁÖ±â
  • ejection period
    ¹ÚÃâ±â
  • incubation period
    Àẹ±â
  • induction period
    À¯µµ±â
  • involutional period
    °»³â±â
  • lag period
    Áõ½ÄÁغñ±â, Áö¿¬±â
  • latent period
    ÀáÀç±â , Àẹ±â
  • neonatal period
    ½Å»ý¾Æ±â
  • paroxysmal period
    ¹ßÀÛ±â
  • postmenopausal period
    Æó°æÈıâ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • perinatal period
    Ãâ»ýÀüÈıâ
  • perinatal mortality
    Ãâ»êÀüÈÄ»ç¸Á·ü
  • perinatal
    Ãâ»ýÀüÈıâ-
  • perinatal mortality rate
    Ãâ»ýÀüÈıâ»ç¸Á·ü
  • absolute refractory period
    Àý´ëºÒÀÀ±â
  • age-period cohort analysis
    ¿¬·É±â°£ÄÚȣƮºÐ¼®
  • childbearing period
    ÀӽŰ¡´É±â°£
  • communicable period
    Àü¿°±â
  • definitive fetal period
    žƿϼº±â
  • ejection period
    ¹ÚÃâ±â
  • embryonic period
    ¹è¾Æ±â
  • extrinsic incubation period
    ¿ÜÀẹ±â, ¹Ù±ùÀẹ±â
  • fetal period
    žƱâ
  • functional refractory period
    ±â´ÉÀûºÒÀÀ±â
  • gestational period
    ÀӽűⰣ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Vibrio fetus infections
    žÆÀ¯»ê±Õ°¨¿°Áõ.
  • SDA= specific dynamic action
    ƯÀ̵¿Àû ÀÛ¿ë.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
  • antigen, species-specific
    Á¾Æ¯ÀÌÇ׿ø
  • antigen, tumor-specific
    Á¾¾çƯÀÌÇ׿ø
  • antigen, tumor-specific transplantation
    Á¾¾çƯÀÌ À̽ÄÇ׿ø
  • antigen,tumor-specific transplantation
    Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
  • granulocyte-specific antigens
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • group specific C carbohydrate
    ±ºÆ¯ÀÌ C´Ù´çü.
  • group-specific
    ±ºÆ¯ÀÌÀÇ
  • group-specific C carbohydrate
    ±ºÆ¯ÀÌ C ź¼öÈ­¹°
  • group-specific antigen
    ±ºÆ¯ÀÌÇ׿ø
  • group-specific antigen
    ±º-ƯÀÌÇ׿ø
  • idiotype specific regulatory cell
    °³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
  • immunity, specific
    ƯÀ̸鿪
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • perinatal period
    Ãâ»ýÀüÈıâ
  • perinatal
    ÁÖ»ê±â(ñ²ß§Ñ¢)ÀÇ
  • perinatal deafness
    ÁÖ»ê±â³ó
  • perinatal mortality
    ÁÖ»ê±â»ç¸Á(Ì¡Ë×Ë»Ë×ËÎ).
  • perinatal mortality rate
    ÁÖ»ê±â»ç¸Á·ü(ÊÙË×ËÎËô).
  • mycotic infections
    Áø±Õ°¨¿°Áõ(òØÐ¶Êïæøñø).
  • resistance to infections
    °¨¿°ÀúÇ×¼º(Êïæøî½ù÷àõ).
  • sexually transmitted infections
    ¼º¸Å°³°¨¿°(àõØÚË¿Êïæø)
  • skin infections
    ÇǺΰ¨¿°(Áõ)(¡­Êïæøñø).
  • skin infections
    ÇǺΰ¨¿°(Áõ)(¡­Êïæøñø)
  • superficial fungus infections
    Ç¥À缺 Áø±Õ°¨¿°(øúî¤àõòØÐ¶Êïæø).
  • transfusion-transmitted infections
    ¼öÇ÷ÀüÆÄ¼º°¨¿°
  • absolute refractory period
    Àý´ëºÒÀÀ±â(¡­ÝÕëëÑ¢)
  • alveolar period
    ²Ê¸®½Ã±â
  • canalicular period
    ¼¼°ü½Ã±â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Perinatal period
    Ãâ»ýÀüÈıâ
    [¿¾ ¿ë¾î] ºÐ¸¸ÀüÈıâ
  • Pseudoglandular period
    °ÅÁþ»ù½Ã±â
    [¿¾ ¿ë¾î] À§¼±±â
  • Alveolar period
    ²Ê¸®½Ã±â
    [¿¾ ¿ë¾î] ÆóÆ÷±â
  • Prenatal period
    ºÐ¸¸Àü±â
    [¿¾ ¿ë¾î] ºÐ¸¸Àü±â
  • Postnatal period
    ºÐ¸¸Èıâ
    [¿¾ ¿ë¾î] ºÐ¸¸Èıâ
  • Canalicular period
    ¼¼°ü½Ã±â
    [¿¾ ¿ë¾î] ¼¼°ü±â
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Initial period of neural groove
    ½Å°æ°í¶ûÃʱâ
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÀü±â
  • Period of neural tube
    ½Å°æ°ü±â
    [¿¾ ¿ë¾î] ½Å°æ°ü±â
  • Neonatal period
    ½Å»ý¾Æ±â
    [¿¾ ¿ë¾î] ½Å»ý¾Æ±â
  • Intermitotic period [Interphase]
    À¯»çºÐ¿­»çÀ̱â
    [¿¾ ¿ë¾î] °£±â
  • Mesoderm of the period of branchiogenesis
    ÀεαÁÀ̹߻ý±âÁ߹迱
    [¿¾ ¿ë¾î] ÀεαÃ[»õ±Ã]¹ß»ý±âÁ߹迱
  • Final period of branchial arch
    ÀεαÁÀÌÁ¾±â
    [¿¾ ¿ë¾î] »õ±ÃÁ¾±â
  • Initial period of pharyngeal arch
    ÀεαÁÀÌÃʱâ
    [¿¾ ¿ë¾î] ÀεαÃÀü±â(»õ±ÃÀü±â)
  • Gestational period
    Àӽűâ
    [¿¾ ¿ë¾î] Àӽűâ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • specific parasite
    ƯÀ̱â»ýÃæ
  • stage-specific protein
    ¹ßÀ°´Ü°èƯÀ̴ܹéÁú
  • extrinsic incubation period
    ¸ð±â³»Àẹ±â
  • incubation period
    Àẹ±â
  • latent period
    Àẹ±â
  • prepatent period
    ÃæÃ¼Àẹ±â
  • residual period
    ÀÜ·ù±â°£
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conversion period
    Àüȯ±â°£(ï®üµÑ¢Êà)
  • half-period
    ¹Ý±â°£(ÚâÑ¢Êà)
  • incubation period
    Àẹ±â(íÖÜÑÑ¢)
  • induction period
    À¯µµ±â°£(ë¯ÓôÑ¢Êà)
  • lag period
    Áöü½Ã°£(òÀôòãÁÊà)
  • latent period
    Àẹ±â(íÖÜÑÑ¢)
  • long period intersperion
    Àå±â »êÀç(íþѢߤî¤)
  • short period intespersion
    ´Ü±â°£ »êÀç(Ó­Ñ¢Êàߤî¤)
  • unit evolutionary period
    ´ÜÀ§(Ó¤êÈ) ÁøÈ­±â°£ (òäûùÑ¢Êà)
  • apparent specific volume
    ¿Ü°ß(èâ̸) ºñ(Ýï)¿ëÀû(é»îÝ)
  • enzyme-specific electrode
    È¿¼ÒƯÀÌ Àü±Ø (ý£áÈ÷åì¶ï³Ð¿)
  • organ specific enzyme
    ±â°üƯÀÌÈ¿¼Ò(Ðïί÷åì¶ý£áÈ)
  • partial specific quantity
    Æíºñ·®(ø¶ÝïÕá)
  • partial specific volume
    Æíºñ¿ëÀû(ø¶Ýïé»îÝ)
  • plasma-specific enzyme
    Ç÷À寝ÀÌ È¿¼Ò(úìíì÷åì¶ý£áÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mycotic infections
    Áø±Õ°¨¿°Áõ
  • perinatal
    ÁÖ»ê±âÀÇ
  • perinatal mortality
    ÁÖ»ê±â»ç¸Á
  • specific absorption rate [=SAR]
    ƯÀÌÈí¼öÀ²
  • specific inflammation
    ƯÀ̼º¿°Áõ
  • incubation period
    Àẹ±â, º¸¿Â±â°£, ¹è¾ç±â°£
  • latent period
    Àẹ±â, Àẹ½Ã, ÀáÀڱؽÃ, Àẹ±â°£
  • period
    ÁÖ±â, ±â, ±â°£, ½Ã´ë
  • pulse repetition period
    ÆÞ½º¹Ýº¹ÁÖ±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HFRS Hemorrhagic Fever with Renal Syndrome [HP 849-50]
  = Korean Hemorrhagic Fever
&nbs...
IP icterus praecox; imaging plate; immune precipitate; immunoblastic plasma; immunoperoxidase technique...
STANDOUT soft thresholding and depth cueing of unspecified techniques
URD unspecified respiratory disease; upper respiratory disease
CHRONIC chronic disease, rheumatoid arthritis, neoplasms, infections, cryoglobulinemia [conditions in which ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CPP Collaborative Perinatal Project
NCPP National Collaborative Perinatal Project
PA Perinatal Asphyxia
PNM Perinatal mortality
PMR Perinatal mortality rate
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • P39.9
    Infections specific to the perinatal period, unspecified
    »ó¼¼ºÒ¸íÀÇ Ãâ»ýÀüÈı⿡ ƯÀÌÇÑ °¨¿°
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • perinatal period
    Ãâ»ý ÀüÈıâ
  • unspecified
    ºñƯÀ̼º
    ´Ù¸¥ °ÍÇÏ°í¸¸ Ưº°È÷ °áÇÕÀ» ÇÑ´ÙµçÁö ¹ÝÀÀÇϴ ƯÀ̼ºÀÌ ¾ø´Â.
  • perinatal deafness
    ÁÖ»ê±â ³ó
  • perinatal mortality
    ÁÖ»ê±â »ç¸Á
  • cell cycle-non specific
    ¼¼Æ÷ Áֱ⠺ñƯÀ̼º Á¦Á¦
  • donor-specific phage
    °ø¿©±Õ ƯÀÌ ÆÄÁö
  • nociceptive specific
    Ä§ÇØ ¼ö¿ë¼º ƯÀ̼º, À¯ÇØ ¼ö¿ë¼º ƯÀ̼º
  • nociceptive-specific cell
    Ä§ÇØ ¼ö¿ë-ƯÀ̼º ¼¼Æ÷, À¯ÇØ ¼ö¿ë-ƯÀ̼º ¼¼Æ÷
  • nociceptive-specific neuron
    Ä§ÇØ ¼ö¿ë-ƯÀ̼º ´º¿ì·±, À¯ÇØ ¼ö¿ë-ƯÀ̼º ´º¿ì·±
  • non-specific arousal system
    ºñƯÀ̼º °¢¼º°è
  • non-specific response
    ºñƯÀ̼º ¹ÝÀÀ
  • specific
    ƯÀÌÇÑ, Á¾ÀÇ, Á¾Á·ÀÇ, ƯÀÌÀÇ, ƯÀ̼ºÀÇ, ƯÀÌÀûÀÎ
    1. ÇÑ Á¾·ùÀÇ ¹Ì»ý¹°¿¡ ÀÇÇØ¼­ »ê»ýµÇ´Â. 2. Ư¼ö¼ºÀÇ. Àû¿ë, È¿°ú µîÀÌ Æ¯Á¤ÇÑ ±¸Á¶, ±â´É µî¿¡ ÇÑÁ¤µÈ. 3. ƯȿÀÇ ¾î¶² ƯÁ¤ Áúȯ¿¡ ´ëÇØ¼­ Ưº°È÷ À¯È¿ÇÑ ÀǾàǰ. 4. ¸é¿ªÇп¡ À־ ´ëÀÀÇÏ´Â Ç×ü¿¡ ´ëÇÑ Ç׿øÀÇ Æ¯º°ÇÑ Ä£È­¼º¿¡ °üÇÑ.
  • specific activity
    ƯÀÌ È°¼º, ƯÀÌ È°¼ºµµ, ºñȰ¼º, ºñȰ¼ºµµ
  • specific alopecia
    Ư¼ö Å»¸ðÁõ
  • specific congenital heart defects
    °³º° º´¼Ò
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
site-specific DNA-methyltransferase (adenine-specific) <enzyme> An enzyme responsible for producing a species-characteristic methylation pattern on adenine residues in a specific short base sequence in the host cell DNA. The enzyme catalyses the methylation of DNA adenine in the presence of s-adenosyl-l-methionine to form DNA containing 6-methylaminopurine and s-adenosyl-l-homocysteine.
Registry number: EC 2.1.1.72
(12 Dec 1998)
site-specific DNA methyltransferase (cytosine-specific) <enzyme> An enzyme responsible for producing a species-characteristic methylation pattern on cytosine residues in a specific short base sequence in the host cell's DNA. The enzyme catalyses the methylation of DNA cytosine in the presence of s-adenosyl-l-methionine to form s-adenosyl-l-homocysteine and DNA containing 5-methylcytosine.
Registry number: EC 2.1.1.73
(12 Dec 1998)
perinatal <paediatrics> Pertaining to or occurring in the period shortly before and after birth, variously defined as beginning with completion of the twentieth to twenty eighth week of gestation and ending 7 to 28 days after birth.
Origin: L. Natus = born
(18 Nov 1997)
perinatal care The care and management of the foetus and newborn infant in the perinatal period before, during, and after delivery.
(12 Dec 1998)
perinatal death An inclusive term referring to both stillborn infants and neonatal death's.
(05 Mar 2000)
perinatal medicine The branch of medicine dealing with the foetus and infant during the perinatal period. The perinatal period begins with the twenty-eighth week of gestation and ends twenty-eight days after birth.
(12 Dec 1998)
perinatal mortality Mortality around the time of birth, conventionally limited to the period from 28 weeks gestation to one week postnatal.
(05 Mar 2000)
perinatal mortality rate The number of stillborn infants of 24 completed weeks or more plus the number of deaths occurring under 7 days of life divided by the number of stillborn infants of 24 weeks or more gestation plus all liveborn infants in the same population, regardless of the period of gestation.
(05 Mar 2000)
perinatal torsion Tends to be extravaginal type.
(05 Mar 2000)
perinatal transmission <microbiology, paediatrics> Transmission of a pathogen, such as HIV, from mother to baby during birth.
See: Vertical Transmission.
(09 Oct 1997)
absolute refractory period The period following excitation when no response is possible regardless of the intensity of the stimulus.
(05 Mar 2000)
alabama period <geology> A period in the American eocene, the lowest in the tertiary age except the lignitic.
Source: Websters Dictionary
(01 Mar 1998)
anaesthesia recovery period The period of emergence from general anaesthesia, where different elements of consciousness return at different rates.
(12 Dec 1998)
Gap1 period The period of the cell cycle after cell division when there is synthesis of RNA and protein; it may last for a few hours in rapidly growing tissue or a lifetime in non-renewing cells such as nerve cells.
Synonym: Gap1 phase, postmitotic phase.
(05 Mar 2000)
Gap2 period The period in the cell cycle when synthesis of DNA is completed but before mitosis begins.
Synonym: Gap2 phase, premitotic phase.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • perinatal
    ÁÖ»ý±âÀÇ;ÁÖ»ê±âÀÇ
  • unspecified
    Ư±â
  • specific
    ƯÁ¤ÇÑ,Ưº°ÇÑ
  • specific
    Ư¼öÇÑ;µ¶Æ¯ÇÑ;¸íÈ®ÇÑ;Á¾ÀÇ;Ưȿ ÀÖ´Â
  • specific duty
    Á¾·®¼¼
  • specific gravity
    ºñÁß
  • specific heat
    ºñ¿­
  • period
    ±â°£,½Ã´ë,Á¾ÁöºÎ
  • cooling-off period
    ³Ã°¢ ±â°£
  • glacial epoch(period)
    ºùÇϱâ(½Ã´ë)
  • glacial period
    ºùÇÏ ½Ã´ë
  • grace period
    À¯¿¹±â°£
  • halflife period
    (¹æ»ç¼º ¿ø¼Ò µîÀÇ)¹Ý°¨±â
  • honeymoon period
    (¹Ì)(´ëÅë·É ÃëÀÓÈÄ ¾à 3°³¿ù°£ÀÇ È£ÀǸ¦ ¹Þ´Â)¹Ð¿ù ±â°£
  • monthly period
    ¿ù°æ(±â°£)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á